NASDAQ$ISPR

Ispire Technology Inc · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

Reported strong financial results with revenue increase and strategic market expansion.

Ispire Technology Inc. reported a 59.1% increase in overall revenue to $42.9 million for the fiscal first quarter of 2024. The company's growth was driven by significant increases in cannabis and tobacco vaping product revenues, reflecting successful U.S. market expansion and positive market reception to their products.

  • Overall revenues increased by 59.1% year-over-year.
  • Cannabis vaping product revenues increased by 116.8% compared to the same period last year.
  • Tobacco vaping product revenues increased by 34.8% compared to the same period last year.
  • A new manufacturing facility in Malaysia was established, signaling readiness for scalable operations in the Southeast Asian market.

Headline financials

Total Revenue

$42.9M

Previous: $24.1M+77.6%
EPS (adj)

-$0.04

Previous: -$0.06+33.3%
Capital Expenditures

-$533K

Previous: $325K-264.2%
Free Cash Flow

-$1.91M

Previous: $1.91M-199.8%
Net Income

-$1.37M

Previous: -$2M+31.3%
Operating Income

-$911K

Previous: -$1.21M+25.0%
Gross Profit

$6.89M

Previous: $4.79M+43.7%
Cash & Equivalents

$25.7M

Previous: $76.1M-66.2%
Total Assets

$88.4M

No prior period
Stock-Based Comp

$968K

No prior period

Revenue & EPS history

Ispire · Revenue · Quarterly

$42.9M

Q1 2024+77.6%vs Q1 2023
Beat estimate in 2 of 11 quarters(18%)
ActualEstimate

Revenue by segment

Ispire · $20.1M total across 1 segment · Q4 2025

  • Vaping Products
    $20.1M

Forward guidance

Ispire projects revenue growth for both cannabis and tobacco vaping products in fiscal year 2024.

Tailwinds

  • Revenue for cannabis vaping products is projected to grow between 100% and 125% from fiscal year 2023, estimating between $80 million and $90 million.
  • Revenue for tobacco vaping products is projected to grow between 33% and 47% from fiscal year 2023, estimating between $100 million and $110 million.
  • The company is on track to meet or exceed revenue projections for both cannabis and tobacco vaping products.
  • Strategic U.S. market expansion is expected to continue driving revenue growth.
  • The company's innovative product, the Ispire ONE™, is expected to transform vaping experiences and set new standards in consumer safety and operational efficiency.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 12 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

-0.2%

Avg return

Earnings day

+0.3%

Avg return

5 days after

-9.1%

Avg return

30 days after

31%

5 / 16 earnings

Positive

+27.2%

Q1 2024

Best reaction

-12.7%

Q2 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2026-5.7%+1.2%+1.2%
Q2 2026+9.5%+14.4%-20.9%
Q1 2026-9.0%-11.0%+26.4%
Q4 2025-1.8%-19.0%-28.9%
Q3 2025-3.7%+6.6%-9.5%
Q2 2025-8.4%-6.6%-14.6%
Q1 2025-4.0%+4.2%-2.6%
Q4 2024+13.4%+7.6%+6.7%
Q3 2024+5.9%+20.2%+18.6%
Q2 2024-12.7%-16.7%-32.4%
Q1 2024+27.2%+2.1%-19.9%
Q4 2023+7.7%+6.0%+0.7%
Q1 2023-9.9%+0.5%-15.6%
Q4 2022-3.9%-1.7%-18.2%
Q3 2023-3.9%-1.7%-18.2%
Q3 2022-3.9%-1.7%-18.2%
Q2 2023
Q2 2021
Q1 2022

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro